| Intravitreal triamcinolone acetonide in patients with macular oedema due to branch retinal vein occlusion: a pilot study. | |
| | |
MedLine Citation:
|
PMID: 16188000 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
PURPOSE: To evaluate treatment of macular oedema due to branch retinal vein occlusion (BRVO) with intravitreal triamcinolone acetonide. METHODS: In a prospective case series, nine patients with macular oedema due to BRVO received an intravitreal injection of 4 mg triamcinolone acetonide. Examination included best-corrected visual acuity (BCVA) for distance and reading, intraocular pressure (IOP) measurement, fluorescein angiography and high resolution imaging by optical coherence tomography, preoperatively and at 1 week, 1 month, 3 and 6 months postoperatively. RESULTS: Preoperative mean BCVAs were 1.3 +/- 0.8 for distance vision, and 1.1 +/- 0.3 for reading acuity, respectively. A significant improvement in reading acuity was observed until 1 month (0.7 +/- 0.4, p = 0.02). No significant reduction in mean macular thickness was observed. CONCLUSIONS: Intravitreal injection of triamcinolone acetonide led to a significant improvement in mean VA in patients with macular oedema due to BRVO. However, the significant effect was not permanent and persisted for only 1 month. |
| | |
Authors:
|
Katharina Krepler; Erdem Ergun; Stefan Sacu; Sibylla Richter-Müksch; Julia Wagner; Michael Stur; Andreas Wedrich |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Acta ophthalmologica Scandinavica Volume: 83 ISSN: 1395-3907 ISO Abbreviation: Acta Ophthalmol Scand Publication Date: 2005 Oct |
Date Detail:
|
Created Date: 2005-09-28 Completed Date: 2005-12-01 Revised Date: 2008-03-17 |
Medline Journal Info:
|
Nlm Unique ID: 9507578 Medline TA: Acta Ophthalmol Scand Country: Denmark |
Other Details:
|
Languages: eng Pagination: 600-4 Citation Subset: IM |
Affiliation:
|
Department of Ophthalmology, Medical University of Vienna, Vienna, Austria. katharina.krepler@meduniwien.ac.at |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged Fluorescein Angiography Glucocorticoids / administration & dosage, therapeutic use* Humans Injections Intraocular Pressure / physiology Macular Edema / drug therapy*, etiology, physiopathology Pilot Projects Prospective Studies Retinal Vein Occlusion / complications, drug therapy*, physiopathology Tomography, Optical Coherence Triamcinolone Acetonide / administration & dosage, therapeutic use* Visual Acuity / physiology Vitreous Body |
| Chemical | |
Reg. No./Substance:
|
0/Glucocorticoids; 76-25-5/Triamcinolone Acetonide |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Intravitreal triamcinalone acetonide for refractory uveitic cystoid macular oedema: longterm managem...
Next Document: Intravitreal triamcinolone acetonide as an adjuvant therapy to panretinal photocoagulation for proli...